These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8275829)

  • 21. Comparison of phenytoin with auranofin and chloroquine in rheumatoid arthritis--a double blind study.
    Rao UR; Naidu MU; Kumar TR; Shobha U; Askar MA; Ahmed N; Sarada P; Venubabu K; Shantaram V; Menon GN
    J Rheumatol; 1995 Jul; 22(7):1235-40. PubMed ID: 7562751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A multicentre double-blind comparison of auranofin, intramuscular gold thiomalate and placebo in patients with psoriatic arthritis.
    Palit J; Hill J; Capell HA; Carey J; Daunt SO; Cawley MI; Bird HA; Nuki G
    Br J Rheumatol; 1990 Aug; 29(4):280-3. PubMed ID: 2116206
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A double-blind placebo-controlled study of auranofin in patients with psoriatic arthritis.
    Carette S; Calin A; McCafferty JP; Wallin BA
    Arthritis Rheum; 1989 Feb; 32(2):158-65. PubMed ID: 2645874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative effectiveness of chrysanol and auranofin in rheumatoid arthritis].
    Atakhodzhaeva ZA; Sigidin IaA
    Ter Arkh; 1987; 59(12):30-3. PubMed ID: 3328906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Follow-up with OM-8980 after a double-blind study of OM-8980 and auranofin in rheumatoid arthritis.
    Vischer TL
    Clin Rheumatol; 1990 Sep; 9(3):356-61. PubMed ID: 2261735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term efficacy and safety of auranofin: a review of clinical experience.
    Blodgett RC; Pietrusko RG
    Scand J Rheumatol Suppl; 1986; 63():67-78. PubMed ID: 3110943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Auranofin in the treatment of juvenile rheumatoid arthritis. Results of the USA-USSR double-blind, placebo-controlled trial. The USA Pediatric Rheumatology Collaborative Study Group. The USSR Cooperative Children's Study Group.
    Giannini EH; Brewer EJ; Kuzmina N; Shaikov A; Wallin B
    Arthritis Rheum; 1990 Apr; 33(4):466-76. PubMed ID: 2183804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Auranofin: 1 mg or 9 mg? The search for the appropriate dose.
    Calin A; Saunders D; Bennett R; Jacox R; Kaplan D; O'Brien W; Paulus HE; Roth S; Weiss T
    J Rheumatol Suppl; 1982; 8():146-8. PubMed ID: 6813476
    [No Abstract]   [Full Text] [Related]  

  • 29. Auranofin in rheumatoid arthritis: what variables could affect the clinical response?
    Harth M
    Agents Actions Suppl; 1988; 24():167-77. PubMed ID: 3055876
    [No Abstract]   [Full Text] [Related]  

  • 30. The efficacy and safety of auranofin compared to placebo in rheumatoid arthritis.
    Katz WA; Alexander S; Bland JH; Blechman W; Bluhm GB; Bonebrake RA; Falbo A; Greenwald RA; Hartman S; Hobbs T; Indenbaum S; Lergier JE; Lanier BG; Lightfoot RW; Phelps P; Sheon RP; Torretti D; Wenger ME; Wilske K
    J Rheumatol Suppl; 1982; 8():173-8. PubMed ID: 6813481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The treatment of ankylosing spondylitis with auranofin (Ridaura)].
    Grasedyck K; Schattenkirchner M; Bandilla K
    Z Rheumatol; 1990; 49(2):98-9. PubMed ID: 2190436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Auranofin (Ridaura). A new peroral agent containing gold used in the treatment of rheumatoid arthritis].
    Glennås A; Kvien TK; Rugstad HE
    Tidsskr Nor Laegeforen; 1986 Oct; 106(29):2438-40. PubMed ID: 3787612
    [No Abstract]   [Full Text] [Related]  

  • 33. Quality of life in patients receiving auranofin therapy: confirmation of efficacy using nontraditional health status measures.
    Morgan GJ
    Scand J Rheumatol Suppl; 1986; 63():29-35. PubMed ID: 3299681
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Auranofin in the treatment of rheumatoid arthritis. Report of 63 cases].
    Tao XL; Dong Y; Zhang NZ
    Zhonghua Nei Ke Za Zhi; 1987 Jul; 26(7):390-3, 444. PubMed ID: 3428027
    [No Abstract]   [Full Text] [Related]  

  • 35. OM-8980 in rheumatoid arthritis: a 6-month double blind placebo controlled multicenter study.
    Brackertz D; Vischer TL
    J Rheumatol; 1989 Jan; 16(1):19-23. PubMed ID: 2654391
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cigarette smoking and the clinical outcome of gold therapy in rheumatoid arthritis.
    Lewis D; Capell HA; McNeil CJ; Smith WE; Brown DH
    J Rheumatol; 1984 Feb; 11(1):111-2. PubMed ID: 6422040
    [No Abstract]   [Full Text] [Related]  

  • 37. Reconsideration of the effects of methotrexate therapy on radiographic progression in rheumatoid arthritis: comment on the article by Weinblatt et al.
    Roces A; Cantabrana A; Hayek M; Dávila M
    Arthritis Rheum; 1994 Jul; 37(7):1114. PubMed ID: 8024623
    [No Abstract]   [Full Text] [Related]  

  • 38. Double-blind trial of recombinant gamma-interferon versus placebo in the treatment of rheumatoid arthritis. 1989.
    Cannon GW; Pincus SH; Emkey RD; Denes A; Cohen SA; Wolfe F; Saway PA; Jaffer AM; Weaver AL; Cogen L; Schindler JD
    Arthritis Rheum; 2008 Feb; 58(2 Suppl):S79-88. PubMed ID: 18240222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Auranofin: its use in patients with rheumatoid arthritis maintained with parenteral chrysotherapy.
    Blackburn WD
    J Rheumatol; 1987 Aug; 14(4):863-4. PubMed ID: 3669000
    [No Abstract]   [Full Text] [Related]  

  • 40. [Comparison between auranofin and chloroquine in the therapy of rheumatoid arthritis].
    Gallo M; La Montagna G; Valentini G
    Clin Ter; 1986 Nov; 119(4):293-8. PubMed ID: 3802739
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.